ABBVIE INC. |
Market Closed -
Other stock markets
|
After market 22:15:10 | |||
| 161.6 USD | +0.19% |
|
161 | -0.37% |
| 05-13 | AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders | MT |
| 05-09 | Medincell: share price rises on resumption of trading | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
Past dividends on AbbVie Inc.
| 11/04/2024 | Quarterly 1.55 USD |
| 11/01/2024 | Quarterly 1.55 USD |
| 11/10/2023 | Quarterly 1.48 USD |
| 12/07/2023 | Quarterly 1.48 USD |
| 12/04/2023 | Quarterly 1.48 USD |
| 11/01/2023 | Quarterly 1.48 USD |
| 12/10/2022 | Quarterly 1.41 USD |
| 13/07/2022 | Quarterly 1.41 USD |
| 12/04/2022 | Quarterly 1.41 USD |
| 12/01/2022 | Quarterly 1.41 USD |
| 13/10/2021 | Quarterly 1.3 USD |
| 13/07/2021 | Quarterly 1.3 USD |
| 13/04/2021 | Quarterly 1.3 USD |
| 13/01/2021 | Quarterly 1.3 USD |
| 13/10/2020 | Quarterly 1.18 USD |
| 13/07/2020 | Quarterly 1.18 USD |
| 13/04/2020 | Quarterly 1.18 USD |
| 13/01/2020 | Quarterly 1.18 USD |
| 10/10/2019 | Quarterly 1.07 USD |
| 11/07/2019 | Quarterly 1.07 USD |
| 11/04/2019 | Quarterly 1.07 USD |
| 13/01/2019 | Quarterly 1.07 USD |
| 11/10/2018 | Quarterly 0.96 USD |
| 11/07/2018 | Quarterly 0.96 USD |
| 11/04/2018 | Quarterly 0.96 USD |
| 10/01/2018 | Quarterly 0.71 USD |
| 11/10/2017 | Quarterly 0.64 USD |
| 11/07/2017 | Quarterly 0.64 USD |
| 10/04/2017 | Quarterly 0.64 USD |
| 10/01/2017 | Quarterly 0.64 USD |
| 11/10/2016 | Quarterly 0.57 USD |
| 12/07/2016 | Quarterly 0.57 USD |
| 12/04/2016 | Quarterly 0.57 USD |
| 12/01/2016 | 0.57 USD |
| 12/10/2015 | 0.51 USD |
| 12/07/2015 | 0.51 USD |
| 12/04/2015 | 0.51 USD |
| 12/01/2015 | 0.49 USD |
| 09/10/2014 | 0.42 USD |
| 10/07/2014 | 0.42 USD |
| 10/04/2014 | 0.42 USD |
| 12/01/2014 | 0.4 USD |
| 09/10/2013 | 0.4 USD |
| 10/07/2013 | 0.4 USD |
| 10/04/2013 | 0.4 USD |
| 10/01/2013 | 0.4 USD |
- Stock Market
- Equities
- ABBV Stock
- Charts AbbVie Inc.
- Total Return chart
